Market Overview

Eidos Therapeutics, Inc. (EIDX)

74.00 +1.13 (1.55%)

Analyst Ratings

DateResearch FirmActionCurrentPT
10/07/20CitigroupDowngradesNeutral73.3
10/06/20BMO CapitalDowngradesMarket Perform
9/22/20GuggenheimDowngradesNeutral
9/08/20CitigroupInitiates Coverage OnBuy80.0
5/14/20JP MorganDowngradesNeutral50.0
5/11/20BarclaysMaintainsUnderweight34.0
5/11/20SVB LeerinkMaintainsOutperform59.0
4/01/20B of A SecuritiesInitiates Coverage OnNeutral51.0
2/27/20Piper SandlerReiteratesOverweight80.0
2/20/20Guggenheim SecuritiesInitiates Coverage OnBuy66.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter